These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study. Hosseinpanah F; Barzin M; Erfani H; Serahati S; Ramezani Tehrani F; Azizi F Clin Endocrinol (Oxf); 2014 Jul; 81(1):52-7. PubMed ID: 23844634 [TBL] [Abstract][Full Text] [Related]
4. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters. Sieminska L; Marek B; Kos-Kudla B; Niedziolka D; Kajdaniuk D; Nowak M; Glogowska-Szelag J J Endocrinol Invest; 2004 Jun; 27(6):528-34. PubMed ID: 15717649 [TBL] [Abstract][Full Text] [Related]
5. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. Ehrmann DA; Kasza K; Azziz R; Legro RS; Ghazzi MN; J Clin Endocrinol Metab; 2005 Jan; 90(1):66-71. PubMed ID: 15507516 [TBL] [Abstract][Full Text] [Related]
6. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study. Ramezani Tehrani F; Minooee S; Azizi F Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947 [TBL] [Abstract][Full Text] [Related]
7. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650 [TBL] [Abstract][Full Text] [Related]
8. Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome. Xiang S; Hua F; Chen L; Tang Y; Jiang X; Liu Z Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):115-8. PubMed ID: 23426706 [TBL] [Abstract][Full Text] [Related]
9. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. Yildiz BO; Yarali H; Oguz H; Bayraktar M J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950 [TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and lipid accumulation product in corelation to body mass index in women with polycystic ovary syndrome. Godinjak A; Godinjak Z; Burekovic A; Surkovic I; Dizdarevic-Bostandzic A; Velija-Asimi Z Med Arch; 2012; 66(6):409-11. PubMed ID: 23409523 [TBL] [Abstract][Full Text] [Related]
12. The lipid accumulation product as a useful index for identifying abnormal glucose regulation in young Korean women. Oh JY; Sung YA; Lee HJ Diabet Med; 2013 Apr; 30(4):436-42. PubMed ID: 23075457 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. Legro RS; Kunselman AR; Dodson WC; Dunaif A J Clin Endocrinol Metab; 1999 Jan; 84(1):165-9. PubMed ID: 9920077 [TBL] [Abstract][Full Text] [Related]
14. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes. Graff SK; Mário FM; Alves BC; Spritzer PM Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153 [TBL] [Abstract][Full Text] [Related]
15. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646 [TBL] [Abstract][Full Text] [Related]
16. The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome. Lee H; Oh JY; Sung YA; Chung H; Cho WY Endocrine; 2009 Oct; 36(2):326-32. PubMed ID: 19688613 [TBL] [Abstract][Full Text] [Related]
17. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment. Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224 [TBL] [Abstract][Full Text] [Related]
18. Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome. Liang SJ; Liou TH; Lin HW; Hsu CS; Tzeng CR; Hsu MI Acta Obstet Gynecol Scand; 2012 Oct; 91(10):1167-72. PubMed ID: 22497305 [TBL] [Abstract][Full Text] [Related]
19. Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome. Möhlig M; Weickert MO; Ghadamgahi E; Arafat AM; Spranger J; Pfeiffer AF; Schöfl C Eur J Endocrinol; 2008 Apr; 158(4):517-23. PubMed ID: 18362299 [TBL] [Abstract][Full Text] [Related]
20. Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance. Mario FM; do Amarante F; Toscani MK; Spritzer PM Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):511-6. PubMed ID: 22576259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]